ATLAS VENTURE FUND XIII, L.P.
Profile
Company Names
ATLAS VENTURE FUND XIII, L.P.
Addresses
300 TECHNOLOGY SQUARE, 8TH FLOOR, CAMBRIDGE, MA 02139
Phone Numbers
857-201-2700
Entity Type:
LIMITED PARTNERSHIP
Industry:
VENTURE CAPITAL FUND
Year Incorporated:
2022
State Incorporated:
DELAWARE
Total Amount Raised:
$450,000,000.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-03-02
$450,000,000.00
$450,000,000.00
$0.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEVIN
BITTERMAN
EXECUTIVE OFFICER
PARASOL THERAPEUTICS INC
| TARIS BIOMEDICAL INC
| BIOLEX THERAPEUTICS, INC.
| FOLLICA, INC
| VISTERRA, INC.
| KALA PHARMACEUTICALS, INC.
| GENOCEA BIOSCIENCES, INC.
| NEURONETICS, INC.
| DIRECT VET MARKETING, INC.
| EDITAS MEDICINE, INC.
| MORPHIC HOLDING, LLC
| ATLAS VENTURE FUND XI, L.P.
| NAVITOR PHARMACEUTICALS, INC.
| AKERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| ATLAS VENTURE FUND XII, L.P.
| KINASET THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| JUDO BIO INC.
| CHROMA MEDICINE, INC.
| REMIX THERAPEUTICS, INC.
| GRO BIOSCIENCES INC.
| ATLAS VENTURE FUND XIV, L.P.
| RENASANT BIO, INC.
| ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
BRUCE
BOOTH
EXECUTIVE OFFICER
MIRAGEN THERAPEUTICS INC
| AVILA THERAPEUTICS INC
| ZAFGEN, INC.
| NIMBUS DISCOVERY, LLC
| ON-Q-ITY, INC.
| NUMERATE INC
| UNUM THERAPEUTICS, INC.
| LYSOSOMAL THERAPEUTICS, INC.
| AVROBIO, INC.
| MAGENTA THERAPEUTICS, INC.
| ATLAS VENTURE FUND XI, L.P.
| RODIN THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| ATLAS VENTURE FUND XII, L.P.
| VIGIL NEUROSCIENCE, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| MATCHPOINT THERAPEUTICS INC.
| ATLAS VENTURE FUND XIV, L.P.
| ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
JEAN-FRANCOIS
FORMELA
EXECUTIVE OFFICER
ARCA BIOPHARMA, INC.
| RESOLVYX PHARMACEUTICALS, INC.
| HORIZON PHARMA, INC.
| ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| COSTIM PHARMACEUTICALS INC.
| CALORICS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| INTELLIA THERAPEUTICS, INC.
| IFM THERAPEUTICS, INC.
| SPERO THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| IFM TRE, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| TRANSLATE BIO, INC.
| KORRO BIO, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| ATLAS VENTURE FUND XII, L.P.
| SCORPION THERAPEUTICS, INC.
| SPERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| AMAGMA, INC.
| IKENA ONCOLOGY, INC.
| ANTARES THERAPEUTICS, INC.
MICHAEL
GLADSTONE
EXECUTIVE OFFICER
DAVID
GRAYZEL
EXECUTIVE OFFICER
ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| AKRIVEIA THERAPEUTICS, LLC
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| AFFINIA THERAPEUTICS INC.
| ATLAS VENTURE FUND XII, L.P.
| AEROVATE THERAPEUTICS, INC.
| XILIO THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| TRIANA BIOMEDICINES, INC.
| ATLAS VENTURE FUND XIII, L.P.
| COMANCHE BIOPHARMA CORP.
| ATLAS VENTURE FUND XIV, L.P.
JASON
RHODES
EXECUTIVE OFFICER
GEMINI THERAPEUTICS, INC.
| ATLAS VENTURE FUND XI, L.P.
| GENERATION BIO CO.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| ATLAS VENTURE FUND XII, L.P.
| DYNE THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| ATLAS VENTURE FUND XIV, L.P.
| ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
